Hematology/Oncology

Top Story

NIH grant to fund research into how lifestyle affects colon cancer outcomes

NIH grant to fund research into how lifestyle affects colon cancer outcomes
February 21, 2017

The NIH awarded an $8.8 million grant to Huntsman Cancer Institute at University of Utah to expand research into how lifestyle and other factors affect colon cancer outcomes.

Neli Ulrich, PhD, senior director of population sciences at Huntsman Cancer Institute, will coordinate the international study. The collaborative effort also includes Fred Hutchinson Cancer Research Center, Moffitt Cancer Center, Cedars-Sinai, Washington University School of Medicine in St. Louis, The University of Tennessee and University of Heidelberg in Germany.

In the Journals

Women with distress, anxiety tend to undergo delayed breast reconstruction

February 21, 2017
Higher levels of distress and anxiety were reported among women who delayed breast reconstruction surgery than in women who did not delay the procedure. The aim of the…
In the Journals Plus

Dyslipidemia associated with CLL

February 21, 2017
Patients who developed chronic lymphocytic leukemia had a higher prevalence of dyslipidemia compared to a control group, according to study results.
In the Journals

Testosterone treatment increases hemoglobin levels, improves anemia in older men

February 21, 2017
Men aged 65 years and older with unexplained anemia may benefit from measurement and treatment of testosterone levels, according to data published in JAMA Internal
In the Journals Plus

Many nonelderly cancer survivors alter prescription drug use to save money

February 21, 2017
Nearly one-third of nonelderly Americans recently diagnosed with cancer change their prescription drug use for financial reasons, according to an analysis published in…
More News Headlines »
CME

Combination Strategies in Melanoma Management: What’s New and What’s Next

This activity is supported by an educational grant from Genentech, Inc.

Melanoma is the sixth most common cancer in the United States and the deadliest form of skin cancer. Although it is…
More »
Video
Meeting News

VIDEO: Down syndrome does not affect management of pediatric ALL

January 5, 2017
More »
Featured
CME

Optimizing the Use of Targeted Therapy in Advanced Melanoma: Where We Are and Where We Are Going

This activity is supported by an educational grant from Genentech.

Melanoma is the deadliest form of skin cancer. Historically, treatment options have been limited for patients with…
More »
Current Issues
View the Current Issue
HemOnc Today
Advertisement
Advertisement